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Abstract
© 2018 Salikhov, Masgutov, Chekunov, Tazetdinova, Masgutova, Teplov, Galimov, Plakseichuk,
Yagudin, Pankov and Rizvanov. In this study we applied autologous fat tissue stromal vascular
fraction (SVF) cells in combination with microfracturing technique in a 36-year-old man with an
osteochondral lesion of the medial femoral condyle 8 months after the injury. Cell material was
generated by fat tissue liposuction from the anterior abdominal wall with subsequent extraction
of the SVF and injected through a mini-arthrotomy portal with subsequent fibrin sealant fixation.
The follow-up period was 2 years. Clinical score improved from 23 to 96 according to IKDC and
from 10 to 90 according to EQ-VAS at 24 months follow-up. Magnetic resonance imaging (MRI)
before the surgery revealed an osteochondral lesion with development of significant trabecular
edema that remained unchanged for 6 months despite conservative treatment. MRI 1 and 2
years after the surgery showed the recovery of the damaged cartilage thickness with somewhat
uneven structure and a decrease in the trabecular edema of the femoral condyle. The use of
SVF  cells  with  fibrin  sealant  fixation  might  be  a  promising  approach  in  the  treatment  of
osteochondral joint lesions. Further studies are required.
http://dx.doi.org/10.3389/fmed.2018.00154
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